Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Facts, Results, and Perspectives of the Current Alzheimer’s Disease Research
José Marco‐Contelles
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 3, pp. 1127-1128
Closed Access | Times Cited: 16

Showing 16 citing articles:

Challenges and Opportunities in Central Nervous System Drug Discovery
Jonathan J. Danon, Tristan A. Reekie, Michael Kassiou
Trends in Chemistry (2019) Vol. 1, Iss. 6, pp. 612-624
Open Access | Times Cited: 69
Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease
Gaia Fancellu, Karam Chand, Daniel Tomás, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 35, Iss. 1, pp. 211-226
Open Access | Times Cited: 56
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Agnieszka Zagórska, Anna Jaromin
Molecules (2020) Vol. 25, Iss. 15, pp. 3337-3337
Open Access | Times Cited: 39
Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents
Mina Saeedi, Atefeh Maleki, Aida Iraji, et al.
Journal of Molecular Structure (2020) Vol. 1229, pp. 129828-129828
Closed Access | Times Cited: 37
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease
Sı́lvia Chaves, Simonetta Resta, Federica Rinaldo, et al.
Molecules (2020) Vol. 25, Iss. 4, pp. 985-985
Open Access | Times Cited: 35
Effect of oral and intraperitoneal administration of walnut-derived pentapeptide PW5 on cognitive impairments in APPSWE/PS1ΔE9 mice
Min Wang, William Kwame Amakye, Congcong Gong, et al.
Free Radical Biology and Medicine (2022) Vol. 180, pp. 191-197
Closed Access | Times Cited: 17
Arylbenzofurans from the Root Bark of Morus alba as Triple Inhibitors of Cholinesterase, β-Site Amyloid Precursor Protein Cleaving Enzyme 1, and Glycogen Synthase Kinase-3β: Relevance to Alzheimer’s Disease
Pradeep Paudel, Su Hui Seong, Yajuan Zhou, et al.
ACS Omega (2019) Vol. 4, Iss. 4, pp. 6283-6294
Open Access | Times Cited: 29
Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization
Marina Costa, Romane Josselin, Diana F. Silva, et al.
Journal of Inorganic Biochemistry (2020) Vol. 206, pp. 111039-111039
Open Access | Times Cited: 17
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
Eva Ramos, Alejandra Palomino‐Antolín, Manuela Bartolini, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1503-1503
Open Access | Times Cited: 12
The allure of targets for novel drugs
Colin J. Suckling
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 472-484
Open Access | Times Cited: 4
In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer's disease like pathology
Chintalapati Manogna, Thirumal Margesan
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Quinazolinone–Hydrazine Cyanoacetamide Hybrids as Potent Multitarget-Directed Druggable Therapeutics against Alzheimer’s Disease: Design, Synthesis, and Biochemical, In Silico, and Mechanistic Analyses
Kandrakonda Yelamanda Rao, Chandran Remya, K.V. Dileep, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 18, pp. 3401-3420
Closed Access | Times Cited: 1
Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
Óscar M. Bautista‐Aguilera, Lhassane Ismaïli, Mourad Chioua, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3913-3913
Open Access | Times Cited: 10
Synthesis, Monoamine Oxidase Inhibition and Computational Analysis of Diversely Substituted N‐Propargylated‐1,3,5‐triazines
Mourad Chioua, Arturo González‐Camuñas, María T. Catarozzo, et al.
ChemistrySelect (2019) Vol. 4, Iss. 28, pp. 8334-8337
Closed Access | Times Cited: 7
“AβTau”, Lobby or Religion?
José Marco‐Contelles
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 10, pp. 1361-1362
Open Access | Times Cited: 1
Búsqueda racional de alcaloides isoquinolínicos del género Zanthoxylum (Rutaceae) como posibles agentes multifuncionales para el tratamiento del Alzheimer
Plazas González, Erika Andrea
(2020)
Closed Access
Page 1

Scroll to top